The burgeoning popularity of retatrutide, initially for metabolic conditions, is creating significant buzz within the British Isles, prompting a notable shift in hormone trends. Availability these medications remains a complex landscape, with National Health Service provision currently limited and specialist practices offering prescriptions at a hi